IOL

The planned acquisition of STAAR includes the EVO family of lenses (EVO ICL) for vision correction for patients with moderate to high myopia with or without astigmatism.

Alcon's Clareon Panoptix Pro IOL enhances cataract surgery with advanced light utilization and low visual disturbance.

Discover how real-world evidence shapes cataract surgery practices, highlighting user satisfaction with enhanced monofocal IOLs at the 2025 ASCRS Annual Meeting.

Bausch + Lomb addresses recent IOL recall, ensuring safety with enhanced protocols and returning enVista lenses to market after thorough investigation.

Celebrating a half-century of progress with Ophthalmology Times.

Updated guidelines characterize IOLs by functional performance over optical design.

The recall was conducted out of an abundance of caution after the company received reports of complications. The cause of said complications could not be immediately explained.

The lens will be available with the Monarch IV manual delivery system in Q2 and the AutonoMe Automated Pre-Loaded Delivery System in Q3.

Toric IOLs outperform femtosecond laser-assisted astigmatic keratotomy in reducing postoperative astigmatism and improving UDVA after cataract surgery.

Monofocal IOLs, along with advanced phacoemulsification technology, offer tailored solutions.

RayTrace has been utilized globally by surgeons since 2008.

The launch follows a CE Mark received late last year.

The Loong Crystal PR IOL is designed for the treatment of myopia in adults ranging from -3.25D to -18.00D.

Enhanced monofocal IOLs provide a slight depth-of-focus boost without compromising contrast, making them a versatile choice for patients seeking improved distance and intermediate vision while still needing glasses for near tasks.

Trending topics and milestone stories from our year in ophthalmology.

The EnVision Summit, co-founded by Bonnie An Henderson, MD, is a unique family-oriented, multispecialty ophthalmology CME conference, along with a newly introduced optometry track. Henderson sits down with Ophthalmology Times to talk about the 2025 conference that will take place February 14 to 17 at the Caribe Hilton San Juan, in Puerto Rico.

According to the company, enVista Envy IOLs will be commercially available in the U.S. on a limited basis in the coming weeks and more broadly in 2025. Bausch + Lomb is also in the process of seeking regulatory approvals for the lens in additional markets.

The TECNIS Odyssey IOL is a new full vision range IOL built on the TECNIS platform.

Option provides surgeons with flexibility and creativity.

The non-diffractive, aspheric IOLs are the second generation of BVI’s ISOPURE family

The IOL, designed with artificial intelligence, will launch at this year's ESCRS Congress in Barcelona, Spain

The device features real-time feedback and other features, allowing residents to hone their skills and expand options for practicing one of the most needed procedures in the country.